No Data
Retail Investors Who Hold 52% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Gained 5.5%, Institutions Profited as Well
Aurinia Pharmaceuticals Up Nearly 14%, on Pace for Largest Percent Increase Since January 2023 -- Data Talk
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options
Aurinia Pharmaceuticals(AUPH.US) Director Buys US$10.82 Million in Common Stock
$Aurinia Pharmaceuticals(AUPH.US)$ Director TANG KEVIN purchased 1.2 million shares of common stock on Dec 5, 6, 9, 2024 at an average price of $9.02 for a total value of $10.82 million.Source:
Aurinia Pharmaceuticals Insider Bought Shares Worth $10,822,000, According to a Recent SEC Filing
Kevin Tang Buys $10.82 Million in Aurinia Pharmaceuticals Shares